Swissray lands $40 million OEM deal

Article

Digital x-ray may represent the future for Swiss x-ray manufacturerSwissray, but it is conventional radiography that is the company'sbread and butter for the time being. Swissray announced this monththat it has signed an agreement to supply conventional

Digital x-ray may represent the future for Swiss x-ray manufacturerSwissray, but it is conventional radiography that is the company'sbread and butter for the time being. Swissray announced this monththat it has signed an agreement to supply conventional x-ray equipmentto a major multinational OEM in a deal valued at $40 million.

Swissray, of Hitzkirch, Switzerland, burst on the U.S. medicalimaging scene at last year's Radiological Society of North Americameeting with AddOn-Bucky, a device to digitize conventional x-rayexams (SCAN 12/13/95). Swissray began installing the first AddOn-Buckyunits earlier this year in Europe.

Swissray has not neglected its conventional x-ray program,however, as evidenced by this month's deal. According to the termsof the agreement, Swissray will supply its radiography productsto the OEM, which will market the devices under its own label.Swissray said that the terms of the agreement precluded it fromdisclosing the name of the OEM.

Swissray will supply equipment to the OEM for the next fourand a half years, with initial shipments to be delivered in thenext 12 months valued at over $8 million.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.